In-Sync was formed in 1989 by president Janet Winkler and offers biopharma clients a range of qual and quant services to help them better understand customers. It is based in Toronto and employs a workforce of 75 people.

The firm will keep its name and become part of the Publicis Healthcare Communications Group (PHCG), with Winkler still at the helm. The agency will report to Sam Welch, COO of PHCG North America.

Nick Colucci (pictured), president and CEO of PHCG, said: “Our healthcare network is strong and growing in part by finding value-creating acquisitions such as In-Sync, which bring tremendous strategy and innovative solutions to biopharma clients and their brands. The In-Sync team is already an impressive and highly sought after company, but we believe they will grow exponentially once they become part of our global network.”

Winkler said that becoming part of PHCG would help In-Sync expand its global presence. She added: “We are also excited by the opportunity to more seamlessly integrate customer insight and branding with the ultimate goal of helping our clients better deliver against the needs of their customers.”